期刊文献+

小牛血红细胞提取物的制备工艺及质量评价 被引量:1

Preparation and Quality Evaluation of Bred Cell Calf Blood Extract
下载PDF
导出
摘要 目的:制备小牛血红细胞提取物并进行质量评价。方法:以小牛血红细胞为原料提取生物活性物质,并与小牛血清提取物及进口同类药品比较评价其生物活性。结果:该制备工艺所制取的小牛血红细胞提取物经鉴别、检查均符合2005年版《中国药典》中的关于原料药的相关规定;经测定小牛血红细胞提取物生物活性显著高于同等浓度下血清提取物,并且与同类进口产品具有相近的产品质量,说明从红细胞中提取出来的原料明显优于从血清中提取的原料。结论:该制备工艺提取易行、质量控制好、制备的活性物质生物活性高,能满足临床用药的要求。 Objective:To study Preparation and quality determination of bred cell calf blood extract, Methods:The bred cell calf blood was used as material to extract bioactive substance.Assessment its potency by compared with calf serum extract and imported similar drugs. Results:The property of the prepared bred cell calf blood extract fitted the description of Chinese Pharmacopeia(2005 editionl. The potency of bred cell calf blood extract was higher than calf serum extract.and it has the same quality standard as solcosery and Actovegin, Conclusion:The preparation technique of bred celt calf blood extract is feasible.the potency of extract bioactive substance is high,reliable quality control and fulfilling the clinical requirement.
作者 阚家义
出处 《中国医药导刊》 2010年第1期163-164,共2页 Chinese Journal of Medicinal Guide
关键词 小牛血红细胞提取物 制备工艺 质量评价 Bred cell calf blood extract:Preparation Quality determination
  • 相关文献

参考文献5

二级参考文献18

  • 1马志忠,汤洪川,贾建军,刘泽亭,尹龄,王国平,朱克,张志萍,张信红,李晖.爱维治治疗老年人脑血管性痴呆[J].中国新药杂志,1994,3(4):35-37. 被引量:4
  • 2王治乔 袁伯俊.新药临床前安全性评价与实践 [M].北京:军事医学科学出版社,1997.78-110.
  • 3Obermaier Kusser B, M hlbacher C, Mushack J, et al Further evidence for a two- step model of glucose- tr_ ansport regulation[J]. Biochem J, 1989, 261: 699
  • 4Siegfried Hoyer, Karen Betz Elimination of the delayed postischemic energy deficit in cerebral cortex and hipp_ ocampus of aged rats with a dried, deproteinized blood extract( Actovegin) [J]. Arch Gerontol Geriatr, 1989, 9: 181
  • 5Groot H, Brecht M, Machicao F Evidence for a factor protective against hypoxic liver parenchyal cell injury in a protein- free blood extract[J]. APRIL, 1990, 68( 1) : 125
  • 6水野美邦.神经内科手册 [M]. 第 2版.日本 : 医学书院出版社 , 1993: 121
  • 7Kanowdki S, Kinzler E, Lehmann E, et al Confirmed cli_ nical efficacy of actovegin in elderly patient with organic brain syndrome[J]. Pharmacopsychiat, 1995, 28: 125
  • 8Vesel SI, Sanik AV The korinfar and actovegin treat_ ment of patients with a chronic ischic disorder of the ce_ rebral circulation[J]. Lik Sprava, 1992, 6: 116
  • 9王雅君 孙旭红 徐淘.奥德金治疗急性脑梗塞临床研究 [J].中国临床医药研究杂志,2001,48:2288-2288.
  • 10Stoltz J, Bartel M Effect of adjuvant infusion therapy of low molecular weight destrans and deproteinized hemo_ deivate( Actovgin) in Fontaine stage IV chronic arterial occlusive diseases[J]. Zentralbl Chir, 1988, 113( 16) : 1 044

共引文献53

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部